Articles dans des revues avec comité de lecture (66)
  1. 48. De Vlieghere, E., Verset, L., Demetter, P., Bracke, M. E., & De Wever, O. (2015). Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics. Virchows Archiv, 467(4), 367-382. doi:10.1007/s00428-015-1818-4
  2. 49. Verset, L., Tommelein, J., Moles Lopez, X., Decaestecker, C., Boterberg, T., De Vlieghere, E., Salmon, I., Mareel, M., Bracke, M. E., De Wever, O., & Demetter, P. (2015). Impact of neoadjuvant therapy on cancer-associated fibroblasts in rectal cancer. Radiotherapy and oncology, 116(3), 449-54. doi:10.1016/j.radonc.2015.05.007
  3. 50. De Vlieghere, E., Remon, J. P., Ceelen, W., Demetter, P., Bracke, M. E., De Geest, B. B., De Wever, O., Gremonprez, F., Verset, L., Mariën, L., Jones, C. C., De Craene, B., Berx, G., Descamps, B., & Vanhove, C. (2015). Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells. Biomaterials, 54, 148-157. doi:10.1016/j.biomaterials.2015.03.012
  4. 51. Fernandez Y Viesca, M., Trepo, E., Degré, D., Gustot, T., Verset, L., Demetter, P., Devière, J., Adler, M., & Moreno, C. (2015). Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease. European journal of gastroenterology & hepatology. doi:10.1097/MEG.0000000000000392
  5. 52. Moles Lopez, X., Barbot, P., Van Eycke, Y.-R., Verset, L., Trepant, A.-L., Larbanoix, L., Salmon, I., & Decaestecker, C. (2015). Registration of whole immunohistochemical slide images: an efficient way to characterize biomarker colocalization. Journal of the American Medical Informatics Association, 22(1), 86-99. doi:10.1136/amiajnl-2014-002710
  6. 53. Tommelein, J., Verset, L., Boterberg, T., Demetter, P., Bracke, M. E., & De Wever, O. (2015). Cancer-associated fibroblasts connect metastasispromoting communication in colorectal cancer. Frontiers in oncology, 5, 63. doi:10.3389/fonc.2015.00063
  7. 54. Hastir, D., Verset, L., Lucidi, V., & Demetter, P. (2013). IgG4 positive lymphoplasmacytic inflammatory pseudotumour mimicking hepatocellular carcinoma. Liver international. doi:10.1111/liv.12319
  8. 55. Verset, L., Tommelein, J., Moles Lopez, X., Decaestecker, C., Mareel, M., Bracke, M. E., Salmon, I., De Wever, O., & Demetter, P. (2013). Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer. British Journal of Cancer, 109(1), 114-120. doi:10.1038/bjc.2013.290
  9. 56. Trepo, E., Ouziel, R., Pradat, P., Momozawa, Y., Quertinmont, E., Gervy, C., Gustot, T., Degré, D., Vercruysse, V., Deltenre, P., Verset, L., Gulbis, B., Franchimont, D., Devière, J., Lemmers, A., & Moreno, C. (2013). Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease. Journal of hepatology, 59(2), 344-350. doi:10.1016/j.jhep.2013.03.024
  10. 57. Demetter, P., D'Haene, N., Verset, L., & Nagy, N. (2013). Pancreatic adenocarcinoma: General histological overview. Acta chirurgica Belgica (Ed. bilingue), 113(2), 71-76.
  11. 58. Hastir, D., Verset, L., & Demetter, P. (2013). Intrahepatic bile duct adenoma with oncocytic features. Liver international, 33(2), 273-273. doi:10.1111/j.1478-3231.2012.02866.x
  12. 59. Degré, D., Lemmers, A., Gustot, T., Ouziel, R., Trepo, E., Demetter, P., Verset, L., Quertinmont, E., Vercruysse, V., Le Moine, O., Devière, J., & Moreno, C. (2012). Hepatic expression of CCL2 in alcoholic liver disease is associated with disease severity and neutrophil infiltrates. Clinical and experimental immunology, 169(3), 302-310. doi:10.1111/j.1365-2249.2012.04609.x
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>